US PTAB IP Litigation
5,620 annotated decisions
Page 99 of 235 · 5,620 total
patent · Jan 17, 2025
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
· PGR2025-00017
Merck has filed a post‑grant review petition challenging Halozyme’s patent on modified PH20 hyaluronidase enzymes, arguing the claims lack adequate written description and enablement. The petition cites extensive expert analysis and prior‑art exhibits to show undue experimentation would be required to identify the claimed mutants.
patent · Jan 17, 2025
Samsung Electronics America, Inc. et al. v.Koninklijke KPN N.V.
· IPR2025-00502
Samsung and Dutch telecom KPN have settled their dispute over U.S. Patent 9,667,669 and jointly moved to terminate the pending inter partes review before the PTAB.
patent terminated or settled · Jan 17, 2025
Samsung Electronics America, Inc. et al. v.Koninklijke KPN N.V.
· IPR2025-00502
Samsung and Dutch telecom firm KPN settled multiple U.S., German and Chinese patent lawsuits via a comprehensive license and non‑assertion agreement covering several KPN patents.
patent · Jan 17, 2025
Coretronic Corporation v.Maxell, LTD.
· IPR2025-00477
Maxell, Ltd. filed a preliminary response urging the PTAB to deny Coretronic’s IPR petition on its projection‑type image display patent. The owner contends the petitioners lack a reasonable likelihood of success because the cited references do not disclose or make obvious the claimed moveable mounting base. The Board is asked to reject the petition.
patent · Jan 17, 2025
Google LLC v.BrodTi Inc.
· IPR2025-00472
Google’s expert Mark Crovella files a reply declaration defending the ’898 patent against Dr. Myler’s claim constructions. He contends the terms are plain, the prior art discloses all claim elements, and the obviousness position should not change.
patent terminated or settled · Jan 17, 2025
AT&T Services, Inc. et al. v.Adaptive Spectrum and Signal Alignment, Inc.
· IPR2025-00451
AT&T and Nokia jointly moved to terminate IPR 2025‑00451 against Adaptive Spectrum's patent 9,954,631, filing a confidential settlement agreement. The PTAB granted the termination, ending the proceeding before any trial was instituted.
patent · Jan 17, 2025
Google LLC v.BrodTi Inc.
· IPR2025-00472
Google filed a reply in IPR2025‑00472 challenging BrodTi’s online‑advertising patent. The petitioner attacks the patent owner’s claim constructions and argues that the prior art makes the claims obvious under §103.
patent · Jan 17, 2025
Coretronic Corporation v.Maxell, LTD.
· IPR2025-00476
Maxell, Ltd. opposes Coretronic and Optoma's IPR petition on U.S. Patent 9,549,226, arguing the petition lacks a reasonable likelihood of success due to flawed claim constructions and insufficient prior‑art support. The Patent Owner seeks denial of institution.
patent denied · Jan 17, 2025
Cambridge Industries USA Inc. et al. v.Applied Optoelectronics, Inc.
· IPR2025-00435
The USPTO Director denied Cambridge Industries' request to review the institution decisions in two IPRs involving Applied Optoelectronics' patents, leaving the prior institution denials in place.
patent all challenged claims unpatentable · Jan 17, 2025
Padagis US LLC et al. v.Neurelis, Inc.
· IPR2025-00464
The PTAB held that all 36 claims of Neurelis’s intranasal benzodiazepine patent are obvious over prior art references Gwozdz, Meezan ’962, and Cartt ’784, rendering the patent entirely unpatentable.
patent · Jan 17, 2025
Cambridge Industries USA Inc. et al. v.Applied Optoelectronics, Inc.
· IPR2025-00435
Cambridge Industries seeks a Director rehearing to overturn the PTAB’s discretionary denial of IPR2025‑00435, arguing that the “settled expectations” rule lacks statutory basis and unfairly protects older patents. The petition cites statutory provisions, case law, and district‑court data to demonstrate the rule’s inconsistency with patent law and the APA.
patent terminated or settled · Jan 17, 2025
AT&T Services, Inc. et al. v.Adaptive Spectrum and Signal Alignment, Inc.
· IPR2025-00451
AT&T and Nokia, together with patent owner ASSIA, have settled their dispute over U.S. Patent 9,954,631 and jointly moved to terminate the inter partes review. The Board is asked to treat the settlement agreement as confidential and end the proceeding.
patent denied · Jan 17, 2025
Tesla, Inc. v.Intellectual Ventures II LLC
· IPR2025-00340
Tesla’s request for rehearing of the Director Review decision was denied after the Board found the petitioner failed to justify inconsistent claim‑construction positions across the IPR and district court.
patent · Jan 17, 2025
Tesla, Inc. v.Intellectual Ventures II LLC
· IPR2025-00340
Tesla seeks Director Review of the PTAB’s decision to institute an IPR on its data‑analytics patent. The Patent Owner argues the Board ignored required consistency in claim construction and the indefiniteness of claim terms, making the institution improper.
patent · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00278
WEC Energy Group and BirchTech Corp. jointly filed a motion to keep their settlement agreement confidential under PTAB rules, invoking 35 U.S.C. § 317(b) and related regulations.
patent terminated or settled · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00278
Berkshire Hathaway Energy and Pacificorp petitioned an IPR on BirchTech's patents. A settlement was reached with MidAmerican Energy, leading the Board to terminate the IPR for MidAmerican while keeping it open for the other petitioners.
patent terminated or settled · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00278
The PTAB terminated the IPRs against BirchTech's patent as to WEC Energy Group following a settlement, but the case remains open for Berkshire Hathaway Energy and other petitioners.
patent · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00278
Berkshire Hathaway Energy and affiliated utilities filed an authorized response urging the PTAB to deny the patent owner's Director Review request. They argue the petitions are timely, lack real‑party or privity issues, and that the Board is the most efficient forum for resolving the mercury‑control patent challenges.
patent · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00278
Berkshire Hathaway Energy’s power subsidiaries and BirchTech have settled their disputes over U.S. Patent 10,343,114, prompting a joint motion to terminate the inter partes review for Interstate Power & Light and Wisconsin Power & Light. The motion cites statutory requirements and public‑policy reasons favoring settlement‑driven termination.
patent terminated or settled · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00274
MidAmerican Energy Company and Birchtech Corp. have settled their dispute over U.S. Patent No. 10,343,114, prompting a joint motion to terminate the inter partes review. The motion cites statutory authority and public policy reasons to end the proceeding before any merits decision.
patent · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00274
Petitioners and Birchtech Corp. filed a joint motion to have their settlement agreements treated as business confidential information, invoking 35 U.S.C. § 317(b) and related Board rules. The request aims to keep the settlement terms separate from the public patent record.
patent · Jan 17, 2025
Tesla, Inc. v.Intellectual Ventures II LLC
· IPR2025-00340
Tesla filed a rehearing request challenging a Director Review order that it says ignored the new Revvo Techs. claim‑construction guidance and conflicted with Federal Circuit precedent on indefiniteness. The company seeks remand for additional briefing.
patent · Jan 17, 2025
Tesla, Inc. v.Intellectual Ventures II LLC
· IPR2025-00340
Court decision.
patent instituted · Jan 17, 2025
Berkshire Hathaway Energy Company et al. v.MES, Inc.
· IPR2025-00274
The PTAB instituted an inter partes review of MES, Inc.'s 10,343,114 B2 mercury‑removal patent after Berkshire Hathaway Energy and affiliates demonstrated a reasonable likelihood of success on claims 1‑30, citing obviousness over multiple prior‑art references.